ID   KMP-2
AC   CVCL_8490
SY   KMP2
DR   CGH-DB; 167-1
DR   Cosmic; 916480
DR   JCRB; JCRB1427
DR   Wikidata; Q54900138
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10091760;
RX   PubMed=18380791;
CC   Population: Japanese.
CC   Doubling time: 16.6 hours (PubMed=10091760).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=18380791).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1427
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser M.U., Ruckert F., Niedergethmann M., Grutzmann R.,
RA   Saeger H.-D.;
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=10091760; DOI=10.1002/(SICI)1097-0142(19990215)85:4<832::AID-CNCR10>3.0.CO;2-7;
RA   Kato M., Shimada Y., Tanaka H., Hosotani R., Ohshio G., Ishizaki K.,
RA   Imamura M.;
RT   "Characterization of six cell lines established from human pancreatic
RT   adenocarcinomas.";
RL   Cancer 85:832-840(1999).
//
RX   PubMed=18380791; DOI=10.1111/j.1349-7006.2008.00779.x; PMCID=PMC11158928;
RA   Suzuki A., Shibata T., Shimada Y., Murakami Y., Horii A.,
RA   Shiratori K., Hirohashi S., Inazawa J., Imoto I.;
RT   "Identification of SMURF1 as a possible target for 7q21.3-22.1
RT   amplification detected in a pancreatic cancer cell line by in-house
RT   array-based comparative genomic hybridization.";
RL   Cancer Sci. 99:986-994(2008).
//